Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update - Yahoo Finance

CBDX Stock  USD 0.0001  0.00  0.00%   
Slightly above 56% of Curative Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Curative Biosciences pink sheet suggests that many investors are alarmed at this time. Curative Biosciences' investing sentiment can be driven by a variety of factors including economic data, Curative Biosciences' earnings reports, geopolitical events, and overall market trends.
  
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Curative Biosciences Fundamental Analysis

We analyze Curative Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curative Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curative Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Curative Biosciences is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Peers

Trending Equities

BBY  2.08   
0%
100.0%
TGT  1.71   
0%
82.0%
INTC  1.69   
0%
81.0%
AA  1.20   
0%
57.0%
AAPL  1.02   
0%
49.0%
C  1.01   
0%
48.0%
HD  0.45   
0%
21.0%
IBM  0.22   
0%
10.0%
UPS  0.03   
0%
1.0%
MET  0.02   
1.0%
0%
CVX  0.11   
5.0%
0%
CVS  0.18   
8.0%
0%
S  0.46   
22.0%
0%
T  0.47   
22.0%
0%
AAL  0.82   
39.0%
0%
WFC  1.35   
64.0%
0%

Additional Tools for Curative Pink Sheet Analysis

When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.